Deliver Your News to the World

Monoclonal Antibody Apolipoprotein A1 from Lee Biosolutions


St. Louis, MO Lee Biosolutions has announced the introduction of a new Monoclonal Antibody anti-Human Apolipoprotein ApoA1 for cardiovascular research.

APOA-1 is a major protein of plasma High Density Lipoprotein. ApoA1 participates in the reverse transport of cholesterol from tissues to the liver for excretion. APOA1 is a cofactor for LCAT, which is responsible for the formation of most plasma cholesteryl esters.

Lee Bio’s monoclonal antibody was purified from Balb/C mice and immunized with highly purified human apoloipoprotein A-1. The mouse spleen and lymph node lymphocytes were fused to firm hybridomas. Lee Biosolutions purified Mouse IgG1 kappa antibody was purified from tissue culture fluid using protein a chromatography. the monoclonal antibody reacts with human apolipoprotein A-1 by elisa and blotting applications

According to Burton Lee , “Lee Biosolutions is in constant communication with its customers to determine trends and anticipate product needs before they happen. Innovative purification procedures continues to be key to the success of Lee Biosolutions business. We are offering a number of related lipoproteins from ApoA1 to ApoE lipoporteins for research. ”

“We understand the critical role our products play in the clinical research process”, Lee said. By maintaining higher purity and quality standards, we aim to provide clients with a wider variety of reliably consistent products which makes us the preferred producer of kidney proteins.

Lee Biosolutions Inc is a leader in the development and marketing of high valued specialty products such Lipoproteins used in Cardiovascular and Lupas research.

Working closely with major diagnostic companies and clinical researchers worldwide in autoimmune studies, cardiovascular and cancer research, Lee Biosolutions, Inc delivers over 400 products to more than 40 countries around the globe. To learn more about how LEE BIOSOLUTIONS helps to make research work, visit


 cardiovascular disease

This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.